Abstract:It is crucial to deliver anticancer drugs to target cells with high precision and efficiency. While nanomaterials have been shown to enhance the delivery efficiency once they reach the target, it remains challenging for precise drug delivery to overcome the nonspecific adsorption and off-target effect. To meet this challenge, we report herein the design of a novel DNA nanostructure to act as a DNA nanoscale precision-guided missile (D-PGM) for highly efficient loading and precise delivery of chemotherapeutic agents to specific target cells. The D-PGM consists of two parts: a warhead (WH) and a guidance/control (GC). The WH is a rod-like DNA nanostructure as a drug carrier, whose trunk is a three-dimensionally self-assembled DNA nanoscale architecture from the programmed hybridization among two palindromic DNA sequences in the x-y dimension and two common DNA oligonucleotides in the z direction, making the WH possess a high payload capacity of drugs. The GC is an aptamer-based logic gate assembled in a highly organized fashion capable of performing cell-subtype-specific recognition via the sequential disassembly, mediated by cell-anchored aptamers. Because of the cooperative effects between the WH and the GC, the GC logic gates operate like the guidance and control system in a precision-guided missile to steer the doxorubicin (DOX)-loaded DNA WH toward target cancer cells, leading to selective and enhanced therapeutic efficacy. Moreover, fluorophores attached to different locations of D-PGM and DOX fluorescence dequenching upon release enable intracellular tracing of the DNA nanostructures and drugs. The results demonstrate that by mimicking the functionalities of a military precision-guided missile to design the sequential disassembly of the GC system in multistimuli-responsive fashion, our intrinsically biocompatible and degradable D-PGM can accurately identify target cancer cells in complex biological milieu and achieve active targeted drug delivery. The success of this strategy paves the way for specific cell identity and targeted cancer therapy.

Nucleic acid biohybrid nanocarriers with high‐therapeutic payload and controllable extended release of daunomycin for cancer therapy

Polymeric Nanostructure Compiled with Multifunctional Components to Exert Tumor-Targeted Delivery of Antiangiogenic Gene for Tumor Growth Suppression

Nanodelivery of a Self-Assembling Prodrug with Exceptionally High Drug Loading Potentiates Chemotherapy Efficacy.

Hollow Polyethyleneimine Nanoparticles with Drug Loaded DNA for Chemotherapeutic Applications

Biomimetic Retractable DNA Nanocarrier with Sensitive Responsivity for Efficient Drug Delivery and Enhanced Photothermal Therapy

Cancer‐Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery

Precision Guided Missile-Like DNA Nanostructure Containing Warhead and Guidance Control for Aptamer-Based Targeted Drug Delivery into Cancer Cells in Vitro and in Vivo.

Structure-Switchable DNA Programmed Disassembly of Nanoparticles for Smart Size Tunability and Cancer-Specific Drug Release.

Nanocarriers with Multi-Locked DNA Valves Targeting Intracellular Tumor-Related Mrnas for Controlled Drug Release

Rationally designed DNA-based nanocarriers

Dual-Targeted Nanocarrier Based on Cell Surface Receptor and Intracellular Mrna: an Effective Strategy for Cancer Cell Imaging and Therapy

A Targeted DNAzyme-Nanocomposite Probe Equipped with Built-in Zn2+ Arsenal for Combined Treatment of Gene Regulation and Drug Delivery

Rational Design of DNA Framework‐Based Hybrid Nanomaterials for Anticancer Drug Delivery

Inhibition of Multidrug Resistance of Cancer Cells by Co‐Delivery of DNA Nanostructures and Drugs Using Porous Silicon Nanoparticles@Giant Liposomes

Dual-Functional DNA Nanogels for Anticancer Drug Delivery

Dna-Hybrid-Gated Multifunctional Mesoporous Silica Nanocarriers for Dual-Targeted and Microrna-Responsive Controlled Drug Delivery**

Co-delivery of Chemotherapeutic Drugs and Immune Adjuvants by Nanoscale DNA Tetrahedrons for Synergistic Cancer Therapy

DNA as Highly Biocompatible Carriers for Drug Delivery

Efficient, Ph-Triggered Drug Delivery Using a Ph-Responsive DNA-conjugated Gold Nanoparticle.

Terminal Pegylated Dna-Gold Nanoparticle Conjugates Offering High Resistance to Nuclease Degradation and Efficient Intracellular Delivery of Dna Binding Agents

A DNA-Based Nano Carrier for Efficient Cancer Therapy